Coverage
-
July 14, 2022
Bristol-Myers Squibb Co. has decided to quietly dismiss its lawsuit seeking to enforce an arbitral award it won in a fight with Novartis Pharma AG over transgenic mice rather than be forced to place the award on the public docket.
2 other articles on this case.
View all »